Corporate News

28 December 2021

Celtarys exclusive fluorescent ligands for cannabinoid receptors used to analyze binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors

Don’t miss the new article by Dr. Gemma Navarro and Dr. Rafael Franco about cannabinoid CB1 and CB2 receptors signaling. They have successfully used CELT-335, one […]
21 December 2021

Celtarys Research awarded as “Best Business Idea” by the Galician Biotechnology Cluster Bioga

Last December 16th the Galician Biotechnology Cluster Bioga announced the winners of the 9th edition of their annual Bioga Awards, which represent a recognition of the […]
24 September 2021

Celtarys Research closes a first investment round of 650,000 euros

The start up Celtarys Research, born at the University of Santiago de Compostela and dedicated to the development of fluorescent tools for drug discovery, has closed […]
6 September 2021

Celtarys Research has been one of the finalists of the 2021 RSC Emerging Technologies Competition

The Emerging Technologies Competition is the Royal Society of Chemistry’s annual initiative for early-stage companies and academic entrepreneurs who want to commercialise their technologies to make […]